Avai Bio (AVAI) Shares Outstanding (Diluted Average) (2018 - 2020)

Avai Bio has disclosed Shares Outstanding (Diluted Average) across 3 years of filings, most recently posting $26.3 million for Q4 2020.

• Shares Outstanding (Diluted Average) for Q4 2020 came in at $26.3 million, up 424.16% year-over-year; the trailing twelve-month figure through Dec 2020 was $26.3 million (up 424.16% YoY), and the FY2020 annual result was $1.0 million, down 78.06% from the prior year.
• Shares Outstanding (Diluted Average) came in at $26.3 million for Q4 2020 at Avai Bio, roughly flat from $26.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $26.3 million in Q2 2020 to a low of $931507.0 in Q1 2018.
• The 3-year median for Shares Outstanding (Diluted Average) is $5.0 million (2018), against an average of $9.2 million.
• Peak annual rise in Shares Outstanding (Diluted Average) reached 424.16% in 2020, while the deepest fall reached 78.06% in 2020.
• Avai Bio's Shares Outstanding (Diluted Average) stood at $5.0 million in 2018, then changed by 0.0% to $5.0 million in 2019, then surged by 424.16% to $26.3 million in 2020.
• The last three Shares Outstanding (Diluted Average) figures came in at $26.3 million (Q4 2020), $26.3 million (Q3 2020), and $26.3 million (Q2 2020), per Business Quant data.